Application of Specialized Amino Acid Solutions in Intensive Care Therapy of Sepsis
Abstract
Sepsis remains one of the leading causes of mortality in intensive care units. Metabolic disorders, protein catabolism, and deficiency of certain amino acids worsen the course of the disease. In recent years, the role of specialized amino acid solutions aimed at correcting metabolic disturbances and modulating the immune response has been actively studied. The most important amino acids are glutamine, arginine, cysteine, ornithine, and taurine, which have pronounced antioxidant, immunomodulatory, and endothelioprotective properties. This review summarizes current data on the use of amino acid solutions in intensive care therapy of sepsis, their impact on outcomes, and perspectives for further use.
References
M. Singer, C. S. Deutschman, C. W. Seymour, et al., “The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3),” JAMA, vol. 315, no. 8, pp. 801–810, 2016.
P. E. Wischmeyer, “Glutamine: mode of action in critical illness,” Crit. Care Med., vol. 35, no. 9 Suppl, pp. S541–S544, 2007.
D. K. Heyland, A. Muscedere, J. Wischmeyer, et al., “A randomized trial of glutamine and antioxidants in critically ill patients,” N. Engl. J. Med., vol. 368, pp. 1489–1497, 2013.
P. C. Calder, “Amino acids and immune function in critical illness,” Br. J. Nutr., vol. 125, no. 6, pp. 618–626, 2021.
V. Cruzat, M. Rogero, and K. Keane, “Glutamine and arginine in critical illness,” Curr. Opin. Clin. Nutr. Metab. Care, vol. 19, no. 1, pp. 71–76, 2016.
B. A. Van Acker, H. M. Luiking, C. Deutz, and H. A. Deutz, “Glutamine: the pivot of our nitrogen economy?,” Clin. Nutr., vol. 18, no. 4, pp. 217–222, 1999.
J. Wernerman, “Clinical use of glutamine supplementation,” J. Nutr., vol. 138, no. 10, pp. 2040S–2044S, 2008.
U. Suchner, K. S. Kuhn, and P. Fürst, “The scientific basis and practical application of glutamine supplementation,” Nutrition, vol. 16, pp. 389–395, 2000.
C. Fuentes-Orozco, R. Anaya-Prado, J. González-Ojeda, et al., “L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in surgical patients,” JPEN J. Parenter. Enteral Nutr., vol. 28, pp. 282–288, 2004.
S. A. McClave, B. E. Taylor, R. G. Martindale, et al., “Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient,” JPEN J. Parenter. Enteral Nutr., vol. 40, no. 2, pp. 159–211, 2016.
Qo‘shimcha manbalar:
M. W. Hulsewé, G. J. van der Hulst, C. H. van Acker, et al., “Glutamine supplementation in critically ill patients: randomized clinical trial,” Clin. Nutr., vol. 23, no. 4, pp. 963–972, 2004.
J. Wernerman and J. Kirketeig, “Amino acid supplementation in critical illness: present evidence and future perspectives,” Curr. Opin. Clin. Nutr. Metab. Care, vol. 18, no. 2, pp. 162–167, 2015.
P. Singer, A. R. Blaser, M. M. Berger, et al., “ESPEN guideline on clinical nutrition in the intensive care unit,” Clin. Nutr., vol. 38, no. 1, pp. 48–79, 2019.
P. C. Calder, “Functional roles of amino acids in immune responses: specific emphasis on glutamine and arginine,” Nutrients, vol. 13, no. 3, p. 649, 2021.
J. Wernerman, “Nutrition and metabolism in the intensive care unit: role of amino acids,” Best Pract. Res. Clin. Anaesthesiol., vol. 25, no. 3, pp. 459–467, 2011.
Copyright (c) 2025 Atashov Aybek Raimberganovich, Nurullaeva Gulmira Amudullaevna , Urinboev Tolibjon Ganjaboy ugli

This work is licensed under a Creative Commons Attribution 4.0 International License.



